An Innovative Medicines Initiative Project for Precision Medicine in DKD
This article is over 5 years old, and the information may therefore be outdated. LAUNCH OF BEAt-DKD – 6 FEBRUARY 2017 BEAt-DKD (“Biomarker Enterprise to Attack Diabetic Kidney Disease”), a unique public private partnership funded by the Innovative Medicines Initiative (IMI), member companies from the European Federation of Pharmaceutical Industries and Associations (EFPIA), the Juvenile Diabetes R
https://www.lunduniversity.lu.se/article/innovative-medicines-initiative-project-precision-medicine-dkd - 2026-06-05
